Chennai-based eye institution and medical research foundation, Sankara Nethralaya, has signed an agreement with the Mauritian government to set up a hospital at Souillac, Mauritius. The new hospital is expected to commence operations in October this year. The facility will offer ophthalmic care to people from Mauritius as well as from neighbouring countries, according to a release.
Thirty-year-old Sankara Nethralaya has been receiving patients from Mauritius on a regular basis for the past 8 years. On an average, it gets 7–8 patients with retinal diseases every week.
To be able to serve the patients of Mauritius better and to eliminate the need for them to be transported here, the Mauritian government invited Sankara Nethralaya to start a branch, the release stated.
Sankara Nethralaya would also be involved in training healthcare professionals in ophthalmology and optometry apart from carrying out research into causation of diabetic retinopathy.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
